Researchers say increased screening of at-risk populations, including those who have never smoked, may improve survival more than any other strategy. Read more
With no direct comparison to the standard of care and limited resources to review applications, researchers say they support the agency’s decision not to approve sintilimab. Read more
5th edition of patient education book released; US FDA moves to prohibit tobacco flavoring. Read more
Winship Cancer Institute announces preceptor opportunity. NICE recommends tepotinib for select patients. Read more
During an episode of IASLC’s Lung Cancer Considered podcast, Dr. Singh provided insight into the US agency’s approval process. Here are some highlights. Read more
Approval opens the door for an immunotherapy-based treatment option prior to surgery for the first time. Read more
Taiwan OKs nivolumab IV infusion in some cases. UK approves atezolizumab for NSCLC. European Commission greenlights lorlatinib for advanced ALK-positive disease. Read more
Sotorasib earns approval in European Union, Japan. Scotland OKs osimertinib. Read more
October 26, 2021—The U.S. Federal Trade Commission’s (FTC’s) recently released Cigarette Report1 showed that the number of cigarettes sold increased from 202.9 billion in 2019 to 203.7 billion in 2020. […] Read more
Value-based care is getting more attention in lung cancer thanks to two new programs offering significant rebates or full refunds should the therapeutic agent be ineffective or intolerable. Pfizer’s pilot […] Read more